![](/img/cover-not-exists.png)
Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer
Jan G. M. Klijn, Frank H. de Jong, Marinus A. Blankenstein, Roel Docter, Jana Alexieva-Figusch, Joan Blonk van der Wijst, Steven W. J. LambertsVolume:
4
Year:
1984
Language:
english
Pages:
12
DOI:
10.1007/bf01806487
File:
PDF, 1.06 MB
english, 1984